Herpes zoster infection and postherpetic neuralgia.
Journal
  Current neurology and neuroscience reports.
Citation
  Curr Neurol Neurosci Rep. 1(6):526-32
Publication date
  2001 Nov
Authors
  Tenser RB
Investigators
  Richard B. Tenser
MeSH headings
  Herpes Zoster
Neuralgia
MeSH qualifiers
  physiopathology
virology
Abstract
  Varicella-zoster virus (VZV), the cause of chicken pox, establishes latent infection in sensory ganglia. Reactivation results in zoster (shingles), sometimes complicated by encephalitis (myelitis). Postherpetic neuralgia (PHN) is the major morbidity of zoster. PHN typically increases in frequency with age. The VZV vaccine, which was developed for children, may be effective in enhancing VZV immune reactivity and decreasing zoster in adults. Early antiviral treatment may be effective in decreasing PHN onset. Several other medications may be useful in treating established PHN. A recent report discussed intrathecal steroid use.
Medline ID
  21894820